Home1JK • FRA
add
Apellis Pharmaceuticals Inc
Previous close
€26.05
Day range
€24.78 - €25.79
Year range
€23.68 - €66.00
Market cap
3.27B USD
Avg Volume
6.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Investopedia
1 day ago
S&P 500 Gains and Losses Today: Palantir Stock Jumps as Listing Heads to
Nasdaq
11.10%
0.90%
1.32%
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 196.83M | 78.29% |
Operating expense | 121.98M | -16.25% |
Net income | -57.44M | 59.04% |
Net profit margin | -29.18 | 77.03% |
Earnings per share | -0.46 | 60.68% |
EBITDA | -46.82M | 65.73% |
Effective tax rate | -1.04% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 403.69M | -13.28% |
Total assets | 901.87M | 10.22% |
Total liabilities | 664.74M | 13.45% |
Total equity | 237.12M | — |
Shares outstanding | 124.39M | — |
Price to book | 13.43 | — |
Return on assets | -13.09% | — |
Return on capital | -16.34% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -57.44M | 59.04% |
Cash from operations | 34.10M | 120.17% |
Cash from investing | 0.00 | 100.00% |
Cash from financing | 2.54M | -55.76% |
Net change in cash | 36.81M | 122.47% |
Free cash flow | 46.97M | 132.83% |
About
Founded
2009
Headquarters
Website
Employees
704
